Albuquerque, NM, June 27, 2017 (GLOBE NEWSWIRE) — Ultra Health, New Mexico’s #1 medical cannabis company with a nationwide presence, has released the first pharmaceutical grade, accurately dosed medical cannabis products to the New Mexico market. The products provide reliable and easy-to-administer dosages of medical cannabis, which has been effective in treating a variety of ailments ranging from PTSD to cancer to chronic pain to epilepsy to Parkinson’s disease, among others.
The new products, developed with proprietary knowledge from Israeli pharmaceutical group Panaxia, include oils, tablets, sublingual tablets, rectal and vaginal suppositories, pastilles, patches, minor burn topicals, facial topicals and massage creams. They range from 10 to 200 milligrams of tetrahydrocannabinol (THC) and 5 to 300 milligrams of cannabidiol (CBD). The revolutionary medical cannabis products are not only discreet, but they provide previously unavailable delivery methods for medical cannabis patients.
The sublingual tablet delivers fast-acting relief to patients who have difficulty swallowing. The cheek area has many tiny blood vessels, which allow for the medication to be absorbed directly into the bloodstream without going into the digestive system, where the effects of the medication could potentially be decreased.